UBS AM
STJ

UBS AM’s St Jude Medical STJ Stock Holding History

UBS AM’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-667,714
Closed -$53.5M – 2533
2016
Q4 		$53.5M Sell
667,714
-8,535
-1% -$677K 0.06% 352
2016
Q3 		$53.9M Buy
676,249
+12,600
+2% +$1.02M 0.06% 344
2016
Q2 		$51.8M Sell
663,649
-192,090
-22% -$13.7M 0.06% 352
2016
Q1 		$47.1M Buy
855,739
+64,095
+8% +$3.49M 0.05% 375
2015
Q4 		$48.9M Sell
791,644
-74,416
-9% -$4.69M 0.06% 363
2015
Q3 		$54.6M Sell
866,060
-104,072
-11% -$7.43M 0.06% 345
2015
Q2 		$70.9M Buy
970,132
+490
+0.1% +$35.4K 0.07% 311
2015
Q1 		$63.4M Sell
969,642
-8,809
-0.9% -$586K 0.06% 344
2014
Q4 		$63.6M Buy
978,451
+15,236
+2% +$981K 0.06% 347
2014
Q3 		$57.9M Sell
963,215
-888,902
-48% -$58.1M 0.06% 353
2014
Q2 		$128M Sell
1,852,117
-661,790
-26% -$42.9M 0.13% 178
2014
Q1 		$164M Buy
2,513,907
+71,037
+3% +$4.62M 0.18% 140
2013
Q4 		$151M Sell
2,442,870
-75,756
-3% -$4.39M 0.17% 147
2013
Q3 		$135M Buy
2,518,626
+22,626
+0.9% +$1.17M 0.17% 151
2013
Q2 		$114M Buy
+2,496,000
New +$108M 0.15% 163

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

UBS AM's STJ Position: Q1 2017 in Review

UBS AM sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 667,714 shares — an estimated $53.5M sold.

UBS AM first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $164M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • UBS AM reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • UBS AM sold 667,714 St Jude Medical shares in Q1 2017, an estimated $53.5M.
  • UBS AM first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • UBS AM's St Jude Medical position peaked at $164M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on UBS AM's 13F filing for Q1 2017, filed 4 May 2017.